Logo

ISB

Metabolic Marker Helps Identify Lung Cancer-Linked Circulating Tumor Cells
Premium

The method, which uses a metabolic marker called hexokinase-2, could be developed to predict cancer patient prognosis and determine progression-free survival.

Merck, ISB Collaborating on COVID-19 Drug, Vaccine Target Discovery

Backed by BARDA, Merck and Institute for Systems Biology are studying multiomic

The Decade in Proteomics: Most Significant Informatics Developments
Premium

Researchers' picks range from emerging tools like deep learning to fundamental issues like false discovery rates and infrastructure for mass spec data sharing.

The Decade in Proteomics: Most Significant New Instrumentation
Premium

Highlights included mass spec-focused developments like data-independent acquisition and ion mobility along with platforms including Thermo Fisher's Q Exactive.

Arivale Shuts Down Personalized Wellness Business

The company published a letter on its website explaining that the genetic and other analyses involved in its services were too costly for customers to support.

Apr 2, 2018

New TCGA Papers Shed Light on Cancer Development

Jul 17, 2017

P100 Wellness Study Uses Omics, Clinical Tests to Track Participants, Advance Systems Medicine

Mar 1, 2017

Arivale Updates Wellness Service With Polygenic Profiles
Premium

Mar 14, 2016

ISB, Providence Health Ally on Healthcare Delivery Research

Jan 7, 2016

ISB Team Develops Method for Improved Analysis of PTMs Using DIA Mass Spec
Premium

Dec 18, 2015

Family Sequencing Study Describes Dominant Negative Form of Fanconi Anemia

Nov 20, 2015

Cancer Genomics Cloud Pilot Developers Provide Update, Open Up Platforms for Early Testing
Premium

Jul 14, 2015

ISB Spinout Arivale Raises $36M in Series B Financing to Provide Science-Based Wellness Advice

May 28, 2015

Leroy Hood Describes Promising Results From Pilot Stage of ISB's 100K Wellness Project

Feb 24, 2015

New Industry-Academic Consortium Aims to Develop Communal Allele Frequency Data Repository
Premium

Jan 29, 2014

Hood Lays out 100K-Patient Longitudinal Research Agenda to Spur Wellness Industry in Next Decade
Premium

Sep 17, 2013

Washington State Fund Pumps $3.7M into Personalized Medicine, Protein Studies

Sep 10, 2013

Paired Ends: Lee Hood
Premium

Sep 6, 2013

People in the News: Lee Hood to Serve as Scientific Advisor to Sera Prognostics
Premium

Aug 14, 2013

People in the News: Leroy Hood
Premium

Aug 13, 2013

Paired Ends: Leroy Hood
Premium

Jul 23, 2013

IP Roundup: Sony, Cornell, Quest, ISB, NuGen, Tufts, Affymetrix, Life Bioscience
Premium

May 31, 2013

Defense Department Gives ISB $7.7M to ID Sepsis Biomarkers Using Next-gen Sequencing

May 14, 2013

Entelos, ISB Partner on Gene Expression Biomarkers

Feb 6, 2013

ISB, AB Sciex Partner on Mass Spec Workflow

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.